US President Donald Trump has said that US may retaliate if India doesn't send the ordered Hydrochloroquine to America

▴ US President Donald Trump
President Trump says US would retaliate if India doesn't send the Hydroxychloroquine

US President Donald Trump has said he would be surprised if India did not allow the export of Hydroxychloroquine tablets to the United States despite a request made to New Delhi over the subject, and hinted at a possible retaliation if India does not lift its hold on the export of the anti-malaria drug used in the treatment of coronavirus patients. Trump speaking from the White House during the Coronavirus taskforce briefing said that India does very well with the US and he sees no reason why India would not lift the hold on the US order of the medicine. He said, " I didn't hear that that was his (Modi) decision. I know that he stopped it for other countries. I spoke to him yesterday, very very good talk, and we'll see whether or not that stays I wouldn't be surprised if he would you know because India's does very well with the United States," Trump said that during his recent phone call with Modi, the latter had said he will consider the request of releasing the order to the US. The US President added, "So I wouldn't be surprised if that was a decision he'd have to tell me that I spoke to him Sunday morning I called him and I said we'd appreciate your allowing our supply to come out. If he doesn't allow it to come out, he doesn't allow it to come out, that would be okay, but of course, there may be retaliation, why wouldn't there be.

Tags : #USA #India #Hydroxychloroquine #COVID-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024